Genetics. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women

By Murray Anna   Webb James   MacSwiney Felicity   Shipley Emma L.   Morton Newton E.  

Human Reproduction, Vol. 14, Iss. 5, 1999-05 ,pp. : 1217-1218

Oxford University Press

Access to resources Recommend Favorite

Medical alternatives to oocyte donation in women with premature ovarian failure: a systematic review

By Robles Ana   Checa Miguel A.   Prat Maria   Carreras Ramón  

Gynecological Endocrinology, Vol. 29, Iss. 7, 2013-07 ,pp. : 632-637

Informa Healthcare

Access to resources Recommend Favorite

Infertility. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial

By Borm G.   Mannaerts B.  

Human Reproduction, Vol. 15, Iss. 7, 2000-07 ,pp. : 1490-1498

Oxford University Press

Access to resources Recommend Favorite

Infertility. Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3

By Syrop C.H.  

Human Reproduction, Vol. 14, Iss. 7, 1999-07 ,pp. : 1752-1756

Oxford University Press

Access to resources Recommend Favorite

Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels.

By Farhi J   Homburg R   Ferber A   Orvieto R   Ben Rafael Z  

Human Reproduction, Vol. 12, Iss. 2, 1997-02 ,pp. : 241-243

Oxford University Press

Access to resources Recommend Favorite